Medium ‐ and long‐chain acylcarnitines are associated with osteoarthritis severity and arterial stiffness in end‐stage osteoarthritis patients: a case‐control study

ConclusionWe found decreased levels of acylcarnitines in OA patients. Furthermore, medium‐and long‐chain acylcarnitines associated independently with arterial stiffness and were related to radiographic severity of OA. Thus, acylcarnities might play an important role in the association between OA and CVD.

Source: APLAR Journal of Rheumatology - January 4, 2018 Category: Rheumatology Authors: Kaspar Tootsi, Jaak Kals, Mihkel Zilmer, Kaido Paapstel, Aigar Ottas, Aare M ärtson Tags: Original Article Source Type: research